Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

Community-acquired pneumonia (CAP) remains a major cause of mortality. The aetiology of CAP has rarely been identified as a mortality risk factor. A prospective study was conducted to assess the prognostic factors of CAP patients admitted to the intensive care unit (Centre Hospitalier Departmental Félix Guyon, St Denis de la Réunion, France), with a special emphasis on microbial aetiology. All variables assessing severity were collected, with a special emphasis on microbial investigations. Among 112 immunocompetent patients (mean±sd age 54.7±15.1 yrs), 84% were male. Severity of CAP was demonstrated by mortality rate (43%), shock (48%), simplified acute physiology score (SAPS; 46.4±21.6) and mechanical ventilation support (82%). Mean risk factor score was 2.2±1.2. Microbiological identification was obtained in 78.6% of cases, with positive blood culture in 33%. Most frequently, microbial agents were Streptococcus pneumoniae and Klebsiella pneumoniae (42% and 22%, respectively). The univariate analysis recorded the usual mortality variables: age, alcohol consumption, SAPS, shock, mechanical ventilation, positive end expiratory pressure level, positive blood culture, multilobar infiltrates on chest radiograph, neutropenia, and acidosis, and found K. pneumoniae (versus S. pneumoniae, and all CAP) as a mortality factor. The multivariate analysis demonstrated that septic shock (relative risk (RR) 141), K. pneumoniae CAP (RR 27), SAPS (RR 10.7) and positive blood culture (RR 2.7) were independent factors related to death. In conclusion, the present study found that the microbial aetiology, Klebsiella pneumoniae, was an independent risk factor for mortality in severe community-acquired pneumonia.

[1]  B. Guery,et al.  A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit , 2006, Intensive Care Medicine.

[2]  A. Torres,et al.  Prognosis factors in severe community-acquired pneumonia: A step forward , 1996, Intensive Care Medicine.

[3]  M. Niederman.  Severe community-acquired pneumonia: What do we need to know to effectively manage patients? , 1996, Intensive Care Medicine.

[4]  B. Trollfors,et al.  Etiology of community-acquired pneumonia in out-patients , 1986, European Journal of Clinical Microbiology.

[5]  C. Feldman,et al.  Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a “severity of illness” score , 2004, Intensive Care Medicine.

[6]  A. Brunelli,et al.  Stair climbing test in lung resection candidates with low predicted postoperative FEV1. , 2003, Chest.

[7]  S. Alfandari,et al.  Impact of positive microbiological diagnosis on management and prognosis of severe community-acquired pneumonia. , 2003, Chest.

[8]  J. Rello,et al.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. , 2003, Chest.

[9]  J. Rello,et al.  Microbiological testing and outcome of patients with severe community-acquired pneumonia. , 2003, Chest.

[10]  Gilles Clermont,et al.  Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. , 2002, American journal of respiratory and critical care medicine.

[11]  W. Lim,et al.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults , 2001, Thorax.

[12]  A. El‐Solh,et al.  Etiology of severe pneumonia in the very elderly. , 2001, American journal of respiratory and critical care medicine.

[13]  J. Friend.  Do smoking parents seek the best advice for their asthmatic children? , 2001, Thorax.

[14]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[15]  J. Bartlett.  Community-acquired pneumonia. , 2009, International journal of clinical practice. Supplement.

[16]  A. Torres,et al.  Severity assessment in community-acquired pneumonia. , 2000, The European respiratory journal.

[17]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  L. Mandell,et al.  Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  R. Wunderink,et al.  The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia. , 1999, Chest.

[20]  A. Torres,et al.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. , 1999, American journal of respiratory and critical care medicine.

[21]  C. VandenBussche,et al.  Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia , 1999, Intensive Care Medicine.

[22]  A. Torres,et al.  Severe community-acquired pneumonia. , 1996, Clinics in chest medicine.

[23]  A. Torres,et al.  Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. , 1999, American journal of respiratory and critical care medicine.

[24]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[25]  M. Niederman,et al.  Severe community-acquired pneumonia. Assessment of severity criteria. , 1998, American journal of respiratory and critical care medicine.

[26]  A. Torres,et al.  Prognostic factors of severe Legionella pneumonia requiring admission to ICU. , 1997, American journal of respiratory and critical care medicine.

[27]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[28]  J. Macfarlane,et al.  Impact of management guidelines on the outcome of severe community acquired pneumonia. , 1997, Thorax.

[29]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[30]  J. Rello,et al.  Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[32]  J. Rello,et al.  Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  C. Feldman,et al.  The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. , 1995, Respiratory medicine.

[34]  R. Wunderink,et al.  Ventilator-associated pneumonia caused by Pseudomonas infection. , 1995, Clinics in chest medicine.

[35]  O. Parra,et al.  Prognostic factors of pneumonia requiring admission to the intensive care unit. , 1995, Chest.

[36]  S. Chevret,et al.  Severe Community-Acquired Pneumonia: Etiology, Epidemiology, and Prognosis Factors , 1994 .

[37]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[38]  J. Rello,et al.  A three-year study of severe community-acquired pneumonia with emphasis on outcome. , 1993, Chest.

[39]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[40]  C. Feldman,et al.  Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. , 1991, Respiration; international review of thoracic diseases.

[41]  J. A. Cuello,et al.  Severe community-acquired pneumonia. Etiology, prognosis, and treatment. , 1990, The American review of respiratory disease.

[42]  T. Marrie,et al.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study. , 1989, Reviews of infectious diseases.

[43]  J. Chastre,et al.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. , 1989, The American review of respiratory disease.

[44]  D. Isaacs,et al.  Neonatal meningitis due to Streptococcus mitis. , 1989, Reviews of infectious diseases.

[45]  C. Feldman,et al.  Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core. , 1989, Intensive care medicine.

[46]  J. Macfarlane,et al.  PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY , 1987, The Lancet.

[47]  D. Rimland,et al.  Alcoholism, leukopenia, and pneumococcal sepsis. , 2015, The American review of respiratory disease.

[48]  M. Woodhead,et al.  Aetiology and outcome of severe community-acquired pneumonia. , 1985, The Journal of infection.

[49]  A. Ortqvist,et al.  Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. , 1985, Scandinavian journal of infectious diseases.